Improving Surface Chemistry |
Natural materials |
|
|
|
|
|
|
Avitene™-MCH |
White, cotton-like appearance; Collagen I, Collagen III, Collagen VI, and Lumican components |
N/A |
Large amounts of activated microglial growth; limited ramified microglial growth |
No significant reduction in FBR compared to control |
N/A |
61 |
Neuroadhesive L1 |
Neuronal adhesion molecule |
83% reduction in microglial adhesion; Good neuronal adhesion |
Good neuroblast growth; limited neuronal cell death |
Reduction in overall gliosis |
N/A |
64, 65a, 65b
|
Natural ECM |
Vary depending on ECM coating type (i.e. astrocyte-derived coating: Collagen VI, Collagen XII, Tenascin N & W, Perlecan, Thromobospondin-1, Fetuin A) |
Good neuronal cell adhesion |
Limited neuronal cell death |
Microglial suppression; reduction of astrogliosis |
No significant electrode impedance following coat application |
61, 62, 63
|
Sodium alginate |
Na, C, N, and O surface chemistry; 400 μm thick coating |
N/A |
Limited neuronal cell death |
Limited immunoreactivity |
N/A |
71 |
Synthetic materials |
|
|
|
|
|
|
Silica sol-gel |
Smooth to rough texture, depending on composition (i.e. octyl, phenyl, aminopropyl, vinyl, glycidyl, octadecyl, thiol, isocyanate, chlorine, or iodine groups) |
Good neuronal cell adhesion |
Good neurite outgrowth; limited astrocyte growth |
Limited FBR |
N/A |
66 |
PEDOT |
Various different properties (i.e. fine textured porous surface with thin nanofilaments) |
Reduced microglial adhesion |
Limited neuronal cell death |
Less severe FBR |
Enhanced charge storage capacity and signal maintenance; enhanced noise and artifact reduction; PEDOT films increased MEA performance compared to controls during experimental period |
67a, 67b, 67c
|
SOD Mimetic |
MnTBAP-antioxidant coating |
N/A |
Limited cytotoxicity |
Reduced microglial activity and superoxide radical production |
Good shielding against reactive oxygen species |
70 |
Nanomaterials/Nanostructures |
Carbon nanotubules on platinum cochlear neural electrodes |
Stable cell adhesion |
Stable cell growth |
N/A |
Decreased impedance and increased capacitance |
69 |
Polypyrrol nanotubes augmented with gold nanoparticles |
N/A |
No significant cytotoxicity |
N/A |
Tenfold decrease in electrochemical impedance |
68 |
Improving Surface Topography |
Parallel nano/micro groves |
Nanopatterned parallel grooves 200 nm wide, 200nm deep, and 300 nm spacing |
No significant difference in cell adhesion |
Larger neuronal density at 4 weeks post implantation compared to control |
No significant reduction of neuroinflammation |
Nanopatterned groves did not degrade during study period |
77 |
Nano/micro pillars |
Microscale pillars with interspacings of 6-8 μm |
Inhibition of platelet adsorption |
N/A |
N/A |
N/A |
59a |
580-800 nm long, 150-200 nm diameter nanopillars |
Decent neural cell adhesion |
More stable neural cell density compared to other tested topographies |
No significant difference to control or other implants |
N/A |
78 |
Nano/micro pores |
Nanoporous gold surface |
Increased neuronal cell coverage, decreased astrocytic coverage |
Good neural cell growth |
Reduced glial scar formation |
Might enhance neuron-electrode coupling |
74 |
Improving Surface Geometry |
Smaller MEAs |
15 μm Michigan electrodes and microwire electrodes |
N/A |
Lower neuronal cell loss compared to larger electrodes |
Less severe FBR compared to larger electrodes |
Microwire electrodes had better signal-to-noise ratio; No significant effect of size on electrode performance |
87 |
Cylindrical shank |
Polyamide cylindrically shaped depth probes |
N/A |
Neuronal death minimal around probe; moderate cell death in neocortex 25 μm from probe |
Weak to moderate FBR around shank |
Reduction in signal-to-noise ratio over the course of 9 weeks; Stable MEA recording activity for several weeks |
88 |
Floating MEAs |
Silicon wafer dummy floating electrodes coated with hexamethyldisilazane, photoresist, and Parylene-C |
N/A |
N/A |
More significant FBR when implanted in spinal cord compared to brain; microglial reactivity did not increase over time |
N/A |
89 |
Stiffness Modifications for MEAs |
Flexible/soft MEAs |
Parylene-C sinusoidal MEAs |
N/A |
Increase in neuronal cell density near probe |
Significantly reduced astrocytic and microglial responses |
N/A |
92 |
Ultraflexible nanoelectric thread |
Seamless tissue integration |
Normal astrocyte density and morphology; complete absence of neuronal degradation |
Complete absence of glial scarring; no observable chronic tissue reaction |
Persistently high signal-to-noise ratio; Stable recording performance for several months |
93 |
Ultrasoft MEAs composed of elastomers and conductive polymers |
Reduced cell body distortion |
Significantly higher neuronal cell density at 8 weeks compared to stiff implants |
Significantly reduced FBR at 8 weeks |
Successful acute nerve stimulation |
95 |
Soft polypyrrol MEAs |
Good MEA-substrate adhesion |
N/A |
N/A |
High conductivity and successful recording of electrocorticograph signals; rat ischiadic nerve stimulation achieved |
96 |
Temporarily stiff MEAs |
|
|
|
|
|
|
Stiff material coating |
Flexible Parylene-C shank electrode with tapered profile; stiffened using applied dextran coating |
Neuronal infiltration of dextran coat area following dissolution |
No significant loss of neuronal cell density |
Very limited glial scar tissue formation after 4 months |
N/A |
97a |
Flexible gold, Parylene-C insulated electrodes; stiffened using applied gelatin coating |
N/A |
N/A |
N/A |
Signal-to-noise ratio remained stable during 3-week period; MEA structure preserved during study period |
98 |
Mechanical adaptivity |
Poly(vinyl acetate)/tunicate cellulose nanocrystal nanocomposite MEAs |
N/A |
Significant neuronal cell loss initially, but neuronal cell recovery was seen over time 100 μm from implant |
Significantly reduced FBR long-term at 2, 6, and 18 weeks |
Stable electrochemical impedance spectra for 16 weeks |
94b, 100
|
Stiff MEAs with surface modifications |
Stiff glass capillary neural probes coated with soft PEG-DMA hydrogel |
N/A |
N/A |
Significant reduction in glial scarring |
N/A |
102 |